Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fuchinoue

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Transplantation|January 12, 1999
Long-term renal function in on-heart-beating donor kidney transplantation: a single-center experienceK Tanabe, T Oshima, T Tokumoto, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 1, 1992
[Optimal dose of cyclosporin in living related kidney transplantation]K Tanabe, K Takahashi, K Sonda, et al.
Transplantation|November 10, 1998
Analysis of postoperative liver function of donors in living-related liver transplantation: comparison of the type of donor hepatectomyT Tojimbara, S Fuchinoue, I Nakajima, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|February 1, 1989
[Infectious diseases in kidney transplant recipients treated with cyclosporin]K Takahashi, T Yagisawa, T Hiroshi, et al.
Diabetes|January 1, 1989
Modulation of prostaglandin metabolism by K-MAP and prevention of toxic effect of cyclosporin on pancreatic islet cellsS Teraoka, T Kawai, T Babazono, et al.
Transplantation Proceedings|November 3, 2004
Results of kidney transplantation in patients receiving MMF- or MMF and basiliximab-containing immunosuppressionT Tojimbara, I Nakajima, S Sato, et al.
Transplantation|June 14, 2000
Sialyl Lewis(x) (CD15s) monitoring as a means to select antirejection therapy in patients with rejection after renal transplantation: CD15s monitoring for treatment and diagnosis in patients with acute rejection after renal transplantationH Ishida, I Koyama, T Sawada, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|May 1, 1997
Plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis of kidney allograft in adult recipientsY Iguchi, K Tanabe, T Yagisawa, et al.
Transplantation Proceedings|April 26, 2005
Comparative study of clinical outcome in kidney transplantation between early steroid withdrawal protocol using basiliximab, calcineurin inhibitor, and mycophenolate mofetil and triple regimen consisting of calcineurin inhibitor, mycophenolate mofetil, and steroidS Teraoka, S Sato, M Sekijima, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 16, 2007
Improved outcomes of renal transplantation from cardiac death donors: a 30-year single center experienceT Tojimbara, S Fuchinoue, K Iwadoh, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Transplantation|January 12, 1999
Long-term renal function in on-heart-beating donor kidney transplantation: a single-center experienceK Tanabe, T Oshima, T Tokumoto, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 1, 1992
[Optimal dose of cyclosporin in living related kidney transplantation]K Tanabe, K Takahashi, K Sonda, et al.
Transplantation|November 10, 1998
Analysis of postoperative liver function of donors in living-related liver transplantation: comparison of the type of donor hepatectomyT Tojimbara, S Fuchinoue, I Nakajima, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|February 1, 1989
[Infectious diseases in kidney transplant recipients treated with cyclosporin]K Takahashi, T Yagisawa, T Hiroshi, et al.
Diabetes|January 1, 1989
Modulation of prostaglandin metabolism by K-MAP and prevention of toxic effect of cyclosporin on pancreatic islet cellsS Teraoka, T Kawai, T Babazono, et al.
Transplantation Proceedings|November 3, 2004
Results of kidney transplantation in patients receiving MMF- or MMF and basiliximab-containing immunosuppressionT Tojimbara, I Nakajima, S Sato, et al.
Transplantation|June 14, 2000
Sialyl Lewis(x) (CD15s) monitoring as a means to select antirejection therapy in patients with rejection after renal transplantation: CD15s monitoring for treatment and diagnosis in patients with acute rejection after renal transplantationH Ishida, I Koyama, T Sawada, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|May 1, 1997
Plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis of kidney allograft in adult recipientsY Iguchi, K Tanabe, T Yagisawa, et al.
Transplantation Proceedings|April 26, 2005
Comparative study of clinical outcome in kidney transplantation between early steroid withdrawal protocol using basiliximab, calcineurin inhibitor, and mycophenolate mofetil and triple regimen consisting of calcineurin inhibitor, mycophenolate mofetil, and steroidS Teraoka, S Sato, M Sekijima, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 16, 2007
Improved outcomes of renal transplantation from cardiac death donors: a 30-year single center experienceT Tojimbara, S Fuchinoue, K Iwadoh, et al.
Pageof 7